Preferred Label : metformin;

Obsolete resource : false;

MeSH definition : A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289);

MeSH synonym : dimethylguanylguanidine; dimethylbiguanidine;

MeSH hyponym : Metformin Hydrochloride; glucophage; Hydrochloride, Metformin; Metformin HCl; HCl, Metformin;

MeSH CAS label : imidodicarbonimidic diamide, N,N-dimethyl-;

MeSH Related Number : 657-24-9 (Metformin); 1115-70-4 (metformin hydrochloride); 786Z46389E;

Registry Number MeSH : 657-24-9;

MeSH annotation : a hypoglycemic;

Wikipedia link : https://en.wikipedia.org/wiki/Metformin;

Codes EINECS : 211-517-8;

Is substance : O;

UNII : 9100L32L2N;

InChIKey : XZWYZXLIPXDOLR-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

https://ansm.sante.fr/actualites/acidose-lactique-et-metformine-un-risque-evitable
2023
false
false
false
France
French
risk management
metformin
acidosis, lactic
Drug-Related side effects and adverse reactions
acidosis, lactic
pharmacovigilance note
guidelines for drug use
patients guideline
renal insufficiency
risk factors
continuity of patient care
hypoglycemic agents
Renal function monitoring (regime/therapy)

---
https://www.has-sante.fr/jcms/p_3317079/fr/glimezit-metformine
2022
false
false
false
France
Metformin Hydrochloride
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
hypoglycemic agents
administration, oral
metformin
adult
child
adolescent
drugs, generic
evaluation of the transparency committee
metformin

---
https://www.has-sante.fr/jcms/p_3376996/fr/sitagliptine/metformine-alter-sitagliptine-/-metformine
2022
false
false
false
France
adult
diabetes mellitus, type 2
treatment outcome
insurance, health, reimbursement
drug combinations
sitagliptin
metformin
administration, oral
hypoglycemic agents
metformin and sitagliptin
Product containing only metformin and sitagliptin in oral dose form (medicinal product form)
dipeptidyl-peptidase iv inhibitors
Metformin Hydrochloride
evaluation of the transparency committee

---
https://www.minerva-ebp.be/FR/Article/2244
2022
Belgium
critical appraisal or critical reading
metformin
cardiovascular prevention
patients
has patient
diabetic complications
diabetic complication, nos
diabetes mellitus, type 2
Sodium-Glucose Transporter 2 Inhibitors
diabetes complications
diabetes non-insulin dependent
Diabetes mellitus type 2

---
https://www.has-sante.fr/jcms/p_3284684/fr/eucreas-50-mg/1000-mg-vildagliptine-/-metformine
2021
false
false
false
France
hypoglycemic agents
Metformin Hydrochloride
drug combinations
Vildagliptin
dipeptidyl-peptidase iv inhibitors
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
evaluation of the transparency committee
metformin
administration, oral
treatment outcome

---
https://www.ssmg.be/wp-content/uploads/RMG/382/RMG382_06-12.pdf
2021
Belgium
journal article
diabetes non-insulin dependent
diabetes mellitus, type 2
Diabetes mellitus type 2
has patient
metformin
patients

---
https://dumas.ccsd.cnrs.fr/dumas-03654287
2021
France
dissertations, academic
COVID-19
Respiratory distress
resuscitation
Emergency and intensive respiratory care
has patient
distress, nos
patients
metformin

---
https://hal.archives-ouvertes.fr/hal-03063819
2021
France
pneumonia, viral
coronavirus infections
journal article
metformin
research
Researches
metaldehyde
metaldehyde
off axis
pandemics
acetaldehyde
COVID-19

---
https://www.has-sante.fr/jcms/p_3283449/fr/komboglyze-metformine-/-saxagliptine
2021
false
false
false
France
evaluation of the transparency committee
saxagliptin
metformin
dipeptides
adamantane
metformin and saxagliptin
treatment outcome
insurance, health, reimbursement
drug combinations
Saxagliptin Hydrochloride
Metformin Hydrochloride
diabetes mellitus, type 2
hypoglycemic agents
drug therapy, combination
administration, oral
adult
incretins
dipeptidyl-peptidase iv inhibitors

---
https://www.has-sante.fr/jcms/p_3283458/fr/jentadueto-linagliptine/-metformine
2021
false
false
false
France
evaluation of the transparency committee
Metformin Hydrochloride
metformin
drug combinations
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
administration, oral
Linagliptin
metformin and linagliptin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
Product containing only linagliptin and metformin in oral dose form (medicinal product form)
incretins
jentadueto

---
https://www.has-sante.fr/jcms/p_3197837/fr/segluromet
2020
false
false
false
France
French
evaluation of the transparency committee
metformin and ertugliflozin
drug combinations
administration, oral
insurance, health, reimbursement
treatment outcome
hypoglycemic agents
adult
diabetes mellitus, type 2
metformin
ertugliflozin
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
metformin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.cochrane.org/fr/CD012906/ENDOC_la-metformine-est-elle-un-traitement-efficace-pour-les-adultes-atteints-de-diabete-de-type-2
2020
France
United Kingdom
review of literature
french abstract
adult
Adult
diabetes mellitus
adulthood
metformin
Adult
Diabetes

---
https://www.has-sante.fr/jcms/p_3218341/fr/synjardy
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
metformin
Metformin Hydrochloride
empagliflozin
metformin and empagliflozin
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
administration, oral
diabetes mellitus, type 2
guidelines for drug use
evaluation of the transparency committee
benzhydryl compounds
glucosides

---
https://www.cochrane.org/fr/CD005552/MENSTR_la-metformine-comparee-la-pilule-contraceptive-orale-combinee-en-cas-de-pilosite-excessive-du-visage
2020
false
true
false
France
United Kingdom
cardiovascular risk
polycystic ovary syndrome
polycystic ovary syndrome
hypoglycemic agents
treatment outcome
metformin
review of literature
french abstract
contraceptives, oral, combined
hirsutism

---
https://www.has-sante.fr/jcms/p_3224069/fr/eucreas
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
drug combinations
administration, oral
Vildagliptin
Metformin Hydrochloride
metformin and vildagliptin
diabetes mellitus, type 2
hypoglycemic agents
metformin

---
https://www.has-sante.fr/jcms/p_3218347/fr/xigduo
2020
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
metformin
dapagliflozin
administration, oral
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
metformin and dapagliflozin
diabetes mellitus, type 2
dapagliflozin
evaluation of the transparency committee
dapagliflozin
glucosides
benzhydryl compounds

---
https://www.cochrane.org/fr/CD008558/metformine-pour-la-preventionle-retardement-du-diabete-de-type-2-dt2-et-les-complications-qui-y-sont
2019
France
United Kingdom
review of literature
french abstract
persons
diabetes mellitus, type 2
Diabetes mellitus type 2
complication, nos
risk
diabetes non-insulin dependent
metformin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/qtrilmet
2019
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
metformin
dapagliflozin
saxagliptin
Metformin Hydrochloride
Metformin Hydrochloride
hypoglycemic agents
hypoglycemic agents
drug approval
europe
metformin, saxagliptin and dapagliflozin
diabetes mellitus, type 2
adult
administration, oral
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Glycated Hemoglobin
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dapagliflozin
metformin
dapagliflozin
saxagliptin
dapagliflozin
dipeptides
adamantane
glucosides
benzhydryl compounds
dapagliflozin
dipeptides
glucosides
benzhydryl compounds

---
https://www.ansm.sante.fr/actualites/information-concernant-les-medicaments-a-base-de-metformine
2019
false
false
false
France
French
metformin
drug contamination
pharmacovigilance note
dimethylnitrosamine
hypoglycemic agents

---
https://medicalforum.ch/fr/detail/doi/fms.2019.03436/
https://doi.org/10.4414/fms.2019.03436
2019
false
false
false
Switzerland
case reports
hypoglycemic agents
acidosis, lactic
journal article
acidosis, lactic
metformin

---
https://papyrus.bib.umontreal.ca/xmlui/handle/1866/19990
http://hdl.handle.net/1866/19990
2018
false
false
false
Canada
French
dissertations, academic
effective
health care costs
direct service costs
adhesives
antidiabetics
adhesive, nos
cause of death
mortality
guideline
persistent
metformin

---
Segluromet ertugliflozin / metformin hydrochloride
https://www.ema.europa.eu/medicines/human/EPAR/Segluromet
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
metformin
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
product surveillance, postmarketing
drug monitoring
metformin and ertugliflozin
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
Metformin Hydrochloride
Metformin Hydrochloride
drug evaluation, preclinical
Sodium-Glucose transporter 2
Sodium-Glucose Transporter 2 Inhibitors
metformin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/portail/jcms/c_2830780/fr/stagid
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
metformin
metformin

---
https://www.ansm.sante.fr/actualites/metformine-et-risque-dacidose-lactique-en-cas-dinsuffisance-renale
2018
false
false
false
France
French
pharmacovigilance note
acidosis, lactic
risk
metformin
renal insufficiency
metformin
administration, oral
Overdose of metformin (disorder)
diabetes mellitus, type 2
hypoglycemic agents
hypoglycemic agents
guidelines for drug use
continuity of patient care
kidney function tests

---
https://www.minerva-ebp.be/FR/Analysis/447
2016
false
false
false
Belgium
French
french abstract
diabetes mellitus, type 2
diabetes mellitus, type 2
vascular diseases
treatment outcome
metformin
life style

---
https://www.jle.com/fr/revues/met/e-docs/metformine_et_deficit_ou_carence_en_vitamine_b12_quel_impact_pour_le_clinicien__308360/article.phtml
10.1684/met.2016.0592
2016
false
false
false
France
French
journal article
metformin
vitamin b 12 deficiency
vitamin b 12 deficiency
diabetes mellitus, type 2
hypoglycemic agents
vitamin b 12 deficiency
vitamin b 12 deficiency
vitamin b 12 deficiency
administration, oral

---
http://www.has-sante.fr/portail/jcms/c_2038125/fr/eucreas-icandra
2015
true
France
French
sulfonylurea compounds
drug therapy, combination
insulin
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Synjardy
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
metformin
metformin
drug combinations
drug approval
europe
hypoglycemic agents
hypoglycemic agents
empagliflozin
empagliflozin
diabetes mellitus, type 2
metformin and empagliflozin
product surveillance, postmarketing
adult
administration, oral
SLC5A2 protein, human
SGLT2 Inhibitor
SGLT2 Inhibitor
drug interactions
pregnancy
breast feeding
aged
drug evaluation, preclinical
Product containing empagliflozin and metformin (medicinal product)
Sodium-Glucose Transporter 2 Inhibitors
benzhydryl compounds
glucosides
benzhydryl compounds
glucosides
Sodium-Glucose transporter 2

---
http://www.has-sante.fr/portail/jcms/c_2022103/fr/metformine-arrow-lab
2015
false
false
false
France
French
evaluation of the transparency committee
metformin

---
http://www.revmed.ch/RMS/2015/RMS-N-477/Metformine-nouvelles-donnees-pour-une-ancienne-molecule
2015
false
false
false
Switzerland
French
journal article
metformin
hypoglycemic agents
diabetes mellitus, type 2
administration, oral
metformin
metformin
hypoglycemic agents
risk assessment
metformin
hypoglycemic agents
acidosis, lactic
treatment outcome
Glycated Hemoglobin
blood glucose

---
http://www.has-sante.fr/portail/jcms/c_2572200/fr/xigduo
http://www.has-sante.fr/portail/jcms/c_2572200/fr/xigduo-dapagliflozine/metformine-antidiabetique
2015
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
hypoglycemic agents
hypoglycemic agents
dapagliflozin
dapagliflozin
metformin and dapagliflozin
metformin
metformin
insurance, health, reimbursement
treatment outcome
administration, oral
drug therapy, combination
diabetes mellitus, type 2
guidelines for drug use
dapagliflozin
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds
glucosides
benzhydryl compounds

---
https://www.ema.europa.eu/medicines/human/EPAR/ebymect
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
dapagliflozin
drug combinations
metformin
metformin and dapagliflozin
hypoglycemic agents
hypoglycemic agents
adult
drug approval
europe
diabetes mellitus, type 2
administration, oral
Sodium-Glucose transporter 2
aged
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical
Glycated Hemoglobin
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
metformin
dapagliflozin
dapagliflozin
dapagliflozin
glucosides
glucosides
benzhydryl compounds
benzhydryl compounds

---
http://www.has-sante.fr/portail/jcms/c_2038104/fr/glucophage
http://www.has-sante.fr/portail/jcms/c_970610/glucophage
2015
false
France
French
diabetes complications
treatment outcome
metformin
administration, oral
hypoglycemic agents
metformin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
child
adolescent
evaluation of the transparency committee

---
http://www.medecinesciences.org/articles/medsci/abs/2014/01/medsci20143001p82/medsci20143001p82.html
http://dx.doi.org/10.1051/medsci/20143001018
2014
false
false
false
France
French
journal article
metformin
hypoglycemic agents
metformin
blood glucose
cardiovascular diseases
diabetes mellitus, type 2
gluconeogenesis
Gluconeogenesis Inhibition
neoplasms
Inhibition of Cell Proliferation
tumor cells, malignant
neurodegenerative diseases
neuroprotective agents

---
http://www.has-sante.fr/portail/jcms/c_1782549/fr/komboglyze
http://www.has-sante.fr/portail/jcms/c_1782549/fr/komboglyze-saxagliptine/metformine-antidiabetique
2014
false
France
French
sulfonylurea compounds
Metformin Hydrochloride
Saxagliptin Hydrochloride
guidelines for drug use
evaluation of the transparency committee
drug combinations
saxagliptin
saxagliptin
metformin and saxagliptin
administration, oral
insurance, health, reimbursement
metformin
metformin
hypoglycemic agents
hypoglycemic agents
adult
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
adamantane
dipeptides
aged
drug therapy, combination
dipeptides
dipeptides

---
http://www.has-sante.fr/portail/jcms/c_1778230/fr/eucreas-/-icandra
http://www.has-sante.fr/portail/jcms/c_1778230/fr/eucreas/icandra-vildagliptine/metformine-antidiabetiques
2014
true
France
French
drug therapy, combination
insulin
guidelines for drug use
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1778245/fr/eucreas-/-icandra
2014
true
France
French
sulfonylurea compounds
drug therapy, combination
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
http://www.prescrire.org/Fr/3/31/49743/0/2014/ArchiveNewsDetails.aspx?page=1
2014
false
false
false
France
French
french abstract
hypoglycemic agents
choice behavior
diabetes mellitus, type 2
first
metformin
hypoglycemic drug, nos

---
http://www.has-sante.fr/portail/jcms/c_1776982/fr/vokanamet
http://www.has-sante.fr/portail/jcms/c_1776982/fr/vokanamet-canagliflozine/metformine
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
administration, oral
drug combinations
metformin and canagliflozin
metformin
hypoglycemic agents
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
adult
Canagliflozin

---
http://www.has-sante.fr/portail/jcms/c_1774100/fr/vipdomet
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
drug combinations
metformin
hypoglycemic agents
Alogliptin Benzoate
metformin and alogliptin
alogliptin
dipeptidyl-peptidase iv inhibitors
incretins
adult
diabetes mellitus, type 2
treatment outcome
insurance, health, reimbursement
drug therapy, combination
piperidines
uracil
uracil

---
http://www.has-sante.fr/portail/jcms/c_1762678/fr/eucreas
2014
false
France
French
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
https://www.revmed.ch/RMS/2013/RMS-394/Toxicite-de-la-metformine-pour-ou-contre-une-restriction-de-ses-contre-indications
2014
false
false
false
Switzerland
French
journal article
metformin
metformin
acidosis, lactic
hypoglycemic agents
hypoglycemic agents
diabetes mellitus, type 2
metformin
metformin
metformin
hypoglycemic agents
guidelines as topic
acidosis, lactic
risk factors
hypoglycemic agents
Contraindications, Procedure
Contraindications, Drug

---
http://www.prescrire.org/Fr/3/31/49379/0/2014/ArchiveNewsDetails.aspx?page=1
2014
false
false
false
France
French
french abstract
first
metformin
diabetes mellitus, type 2
choice behavior

---
https://www.ema.europa.eu/medicines/human/EPAR/Xigduo
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
dapagliflozin
drug combinations
metformin
metformin and dapagliflozin
hypoglycemic agents
hypoglycemic agents
adult
drug approval
europe
diabetes mellitus, type 2
administration, oral
Sodium-Glucose transporter 2
aged
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical
Glycated Hemoglobin
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
metformin
dapagliflozin
dapagliflozin
dapagliflozin
glucosides
glucosides

---
https://www.ema.europa.eu/medicines/human/EPAR/Vokanamet
2014
false
United Kingdom
French
English
drug combinations
drug approval
europe
treatment outcome
combinations of oral blood glucose lowering drugs
metformin
metformin
administration, oral
diabetes mellitus, type 2
hypoglycemic agents
hypoglycemic agents
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
aged
Sodium-Glucose transporter 2
summary of product characteristics
package leaflet
syndication feed
Canagliflozin
Canagliflozin
Sodium-Glucose Transporter 2 Inhibitors

---
http://www.cochrane.org/fr/CD006105
2014
false
false
false
France
United Kingdom
metformin
treatment outcome
polycystic ovary syndrome
meta-analysis
french abstract
fertilization in vitro
metformin
sperm injections, intracytoplasmic

---
https://www.revmed.ch/RMS/2013/RMS-N-395/Utilisation-de-la-metformine-chez-le-patient-diabetique-cardiaque-balance-benefices-risques
2013
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
heart diseases
metformin
risk assessment
hypoglycemic agents
metformin
hypoglycemic agents
acidosis, lactic
acute coronary syndrome
heart failure
coronary disease
myocardial infarction

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68674913
2013
summary of product characteristics
tablets
metformin
saxagliptin

---
http://www.has-sante.fr/portail/jcms/c_1241667/komboglyze
http://www.has-sante.fr/portail/jcms/c_1598723/fr/komboglyze
2013
France
French
evaluation of the transparency committee
drug combinations
saxagliptin
saxagliptin
metformin and saxagliptin
administration, oral
insurance, health, reimbursement
metformin
metformin
hypoglycemic agents
hypoglycemic agents
adult
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
adamantane
dipeptides
aged
clinical trials, phase iii as topic
risk assessment
drug therapy, combination
insulin

---
https://www.minerva-ebp.be/fr/article/100
2013
false
false
minerva-ebm.be
Belgium
French
diabetes mellitus, type 2
metformin
hypoglycemic agents
treatment outcome
critical appraisal or critical reading
risk assessment
diabetic angiopathies
diabetes mellitus, type 2
meta-analysis

---
https://www.minerva-ebp.be/fr/analyses-en-ligne/166
2013
false
false
minerva-ebm.be
Belgium
French
Dutch
critical appraisal or critical reading
pregnancy in diabetics
insulin
metformin
diabetes, gestational
hypoglycemic agents
randomized controlled trials as topic
infant, newborn
birth weight
blood glucose
pregnancy
comparative study

---
https://www.ema.europa.eu/medicines/human/EPAR/Vipdomet
2013
United Kingdom
French
English
alogliptin
metformin
drug combinations
metformin
hypoglycemic agents
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
alogliptin
metformin and alogliptin
drug approval
europe
treatment outcome
adult
diabetes mellitus, type 2
drug therapy, combination
administration, oral
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
syndication feed
piperidines
piperidines
uracil

---
https://rmlg.uliege.be/article/2400
2013
false
true
false
Belgium
French
journal article
metformin
hypoglycemic agents
diabetes mellitus, type 2
risk assessment
renal insufficiency, chronic
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63941223
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69398841
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69939574
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64012517
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64366672
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64750210
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68305834
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66627936
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62942347
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62012422
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63424425
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62575869
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64627492
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69294611
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65127255
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67212074
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61639849
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68117871
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66775970
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68010684
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64248097
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63721362
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67235735
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63432557
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69143260
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62531552
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62009853
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64373211
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64314711
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69116466
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68739916
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68631577
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67030171
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67945144
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64217415
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68466937
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66082820
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60975882
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67935602
2012
France
summary of product characteristics
package leaflet
sitagliptin
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62214025
2012
France
summary of product characteristics
package leaflet
sitagliptin
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60892792
2012
France
summary of product characteristics
package leaflet
tablets
metformin
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62091971
2012
France
summary of product characteristics
package leaflet
tablets
metformin
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63079915
2012
France
summary of product characteristics
package leaflet
metformin
tablets
glyburide
Glucovance

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68505991
2012
France
summary of product characteristics
package leaflet
Glucovance
tablets
metformin
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60990795
2012
France
summary of product characteristics
package leaflet
metformin
powders

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68515487
2012
France
summary of product characteristics
package leaflet
metformin
powders

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65135355
2012
France
summary of product characteristics
package leaflet
metformin
powders

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61507783
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62578477
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60660395
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67706105
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65501475
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62818762
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60269418
2012
France
summary of product characteristics
package leaflet
tablets
metformin
schools, public health

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64592696
2012
France
summary of product characteristics
package leaflet
tablets
metformin
schools, public health

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68885878
2012
France
summary of product characteristics
package leaflet
metformin
schools, public health
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63170941
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66538626
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67816854
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68347388
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64947414
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64754205
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68382713
2012
France
summary of product characteristics
package leaflet
tablets
metformin
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66895877
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69816582
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65937227
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64053300
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62319880
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68319595
2012
France
summary of product characteristics
package leaflet
metformin
france
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64873679
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63146246
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63119726
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65646848
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63701267
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61850725
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68196071
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66238333
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69448283
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61073372
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61039256
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61037255
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61027318
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67335269
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66336261
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60915020
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67495373
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69046402
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61182628
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62844369
2012
France
summary of product characteristics
package leaflet
metformin
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66319493
2012
France
summary of product characteristics
package leaflet
tablets
metformin

---
https://www.ema.europa.eu/medicines/human/EPAR/Competact
2012
United Kingdom
English
French
syndication feed
diabetes mellitus, type 2
thiazolidinediones
hypoglycemic agents
metformin
treatment outcome
drug evaluation
drug combinations
adult
administration, oral
tablets
aged
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
thiazolidinediones
metformin
hypoglycemic agents
drug evaluation, preclinical
drug labeling
drug approval
overweight
metformin and pioglitazone
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
drug evaluation
summary of product characteristics
package leaflet
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Eucreas
2012
United Kingdom
English
French
syndication feed
hypoglycemic agents
pregnancy
nitriles
pyrrolidines
metformin
administration, oral
drug evaluation
treatment outcome
adult
aged
drug interactions
nitriles
pyrrolidines
metformin
drug evaluation, preclinical
drug approval
drug labeling
adamantane
drug combinations
diabetes mellitus, type 2
metformin and vildagliptin
breast feeding
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
drug evaluation
summary of product characteristics
package leaflet
drug therapy, combination
Vildagliptin
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Glubrava
2012
United Kingdom
French
English
syndication feed
hypoglycemic agents
metformin
adult
drug combinations
breast feeding
pregnancy
drug approval
tablets
diabetes mellitus, type 2
drug labeling
treatment outcome
drug evaluation
drug evaluation, preclinical
hypoglycemic agents
thiazolidinediones
metformin
drug interactions
aged
administration, oral
overweight
thiazolidinediones
metformin and pioglitazone
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
package leaflet
summary of product characteristics
drug evaluation
Pioglitazone
Pioglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Zomarist
2012
United Kingdom
English
French
syndication feed
pyrrolidines
adamantane
nitriles
dipeptidyl-peptidase iv inhibitors
drug combinations
metformin
metformin
dipeptidyl-peptidase iv inhibitors
tablets
administration, oral
diabetes mellitus, type 2
hypoglycemic agents
hypoglycemic agents
treatment outcome
drug approval
drug labeling
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
metformin and vildagliptin
package leaflet
summary of product characteristics
drug evaluation
drug therapy, combination
Vildagliptin
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/icandra-previously-vildagliptin-metformin-hydrochloride-novartis
2012
false
United Kingdom
French
English
syndication feed
metformin
hypoglycemic agents
adamantane
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
drug combinations
dipeptidyl-peptidase iv inhibitors
drug approval
drug labeling
treatment outcome
metformin
hypoglycemic agents
tablets
administration, oral
diabetes mellitus, type 2
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
metformin and vildagliptin
drug evaluation
summary of product characteristics
package leaflet
drug therapy, combination
Vildagliptin
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1298568/stagid
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/stagid_05092012_avis_ct12419.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_618898
2012
France
French
metformin
hypoglycemic agents
administration, oral
diabetes mellitus, type 2
insurance, health, reimbursement
metformin
diabetes mellitus, type 1
drug therapy, combination
adult
overweight
evaluation of the transparency committee

---
https://www.ema.europa.eu/medicines/human/EPAR/Komboglyze
2012
United Kingdom
English
French
drug evaluation
summary of product characteristics
package leaflet
syndication feed
dipeptides
dipeptides
adamantane
adult
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical
saxagliptin
metformin
drug combinations
drug approval
treatment outcome
saxagliptin
metformin
administration, oral
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
hypoglycemic agents
hypoglycemic agents
metformin and saxagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Jentadueto
2012
false
United Kingdom
French
English
summary of product characteristics
package leaflet
drug evaluation
syndication feed
Linagliptin
Linagliptin
Product containing linagliptin and metformin in oral dose form (medicinal product form)
aged
drug interactions
pregnancy
fertility
breast feeding
controlled clinical trials as topic
drug evaluation, preclinical
metformin
metformin
drug combinations
metformin and linagliptin
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
hypoglycemic agents
hypoglycemic agents
drug approval
treatment outcome
administration, oral
diabetes mellitus, type 2
adult
drug therapy, combination

---
http://www.has-sante.fr/portail/jcms/c_1298544/jentadueto
http://www.has-sante.fr/portail/jcms/c_1298694/jentadueto-05092012-avis-ct12491
2012
false
France
French
Linagliptin
Linagliptin
Product containing linagliptin and metformin in oral dose form (medicinal product form)
metformin and linagliptin
administration, oral
adult
aged
diabetes mellitus, type 2
drug combinations
drug therapy, combination
Glycated Hemoglobin
hypoglycemic agents
hypoglycemic agents
insurance, health, reimbursement
metformin
metformin
treatment outcome
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
evaluation of the transparency committee

---
http://www.cochrane.org/fr/CD006226
United Kingdom
France
French
meta-analysis
metformin
clomiphene
treatment outcome
fertility agents, female
polycystic ovary syndrome
french abstract

---
http://www.franceculture.fr/emission-science-publique-faut-il-prendre-de-l-aspirine-tous-les-jours-2012-12-07
France
French
aspirin
radio broadcast
scientific and technical information
metformin
hydroxymethylglutaryl-coa reductase inhibitors
acquired immunodeficiency syndrome

---
https://www.jle.com/fr/revues/medecine/med/e-docs/00/04/80/2B/resume.phtml
2012
France
French
metformin
hypoglycemic agents
diabetes mellitus, type 2
journal article
treatment outcome

---
http://www.cochrane.org/fr/CD003053
2012
France
United Kingdom
French
french abstract
meta-analysis
polycystic ovary syndrome
treatment outcome
metformin
hypoglycemic agents
thiazolidinediones
inositol
vitamin B complex
Rosiglitazone
Pioglitazone

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-08/competact_-_ct-10278.pdf
http://www.has-sante.fr/portail/jcms/c_1078997/competact
2011
France
French
evaluation of the transparency committee
drug combinations
thiazolidinediones
diabetes mellitus, type 2
treatment outcome
metformin
administration, oral
hypoglycemic agents
metformin and pioglitazone
insurance, health, reimbursement
overweight
adult
aged
Pioglitazone Hydrochloride
Pioglitazone

---
http://www.lecrat.eu/?s=Metformine
2011
France
French
drug information
metformin
metformin
administration, oral
pregnancy
hypoglycemic agents
diabetes mellitus, type 2
diabetes, gestational
breast feeding

---
https://rmlg.uliege.be/article/2159
2011
false
true
false
Belgium
hypoglycemic agents
journal article
sulfanilamides
metformin
diabetes mellitus, type 2

---
https://rmlg.uliege.be/article/2150
2011
false
true
false
Belgium
diabetes mellitus, type 2
hypoglycemic agents
hypoglycemic agents
hypoglycemic agents
metformin
drug therapy, combination
journal article
diabetes mellitus, type 2

---
http://www.has-sante.fr/portail/display.jsp?id=c_400023
http://www.has-sante.fr/portail/jcms/c_1054871/glucovance
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/glucovance_-_ct-7012.pdf
2011
France
French
Glucovance
glyburide
drug combinations
metformin
hypoglycemic agents
adult
administration, oral
metformin and sulfonylureas
insurance, health, reimbursement
diabetes mellitus, type 2
treatment outcome
glyburide
metformin
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1171505/competact-15-mg-/-850-mg-pioglitazone/metformine-antidiabetique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/competact_06-07-2011_synthese_ct10278.pdf
2011
France
French
administration, oral
drug combinations
metformin
metformin
insurance, health, reimbursement
hypoglycemic agents
hypoglycemic agents
thiazolidinediones
thiazolidinediones
metformin and pioglitazone
diabetes mellitus, type 2
overweight
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
guidelines for drug use
evaluation of the transparency committee
Pioglitazone
Pioglitazone

---
http://www.has-sante.fr/portail/jcms/c_1098669/icandra
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-09/icandra_-_ct9790.pdf
2011
France
French
evaluation of the transparency committee
nitriles
nitriles
pyrrolidines
pyrrolidines
adamantane
drug combinations
administration, oral
metformin
dipeptidyl-peptidase iv inhibitors
metformin and vildagliptin
hypoglycemic agents
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
continuity of patient care
treatment outcome
hypoglycemic agents
metformin
dipeptidyl-peptidase iv inhibitors
Vildagliptin
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69269241
2010
France
French
drug combinations
thiazolidinediones
tablets
administration, oral
metformin
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone maleate
drug information
Rosiglitazone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67283114
2010
France
French
thiazolidinediones
tablets
administration, oral
metformin
drug combinations
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone maleate
drug information
Rosiglitazone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63597249
2010
France
French
thiazolidinediones
tablets
administration, oral
metformin
drug combinations
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone maleate
drug information
Rosiglitazone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68863814
2010
France
French
thiazolidinediones
tablets
administration, oral
metformin
drug combinations
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone maleate
drug information
Rosiglitazone

---
https://www.ema.europa.eu/medicines/human/EPAR/Avandamet
2010
Non renseigné
French
English
syndication feed
diabetes mellitus, type 2
thiazoles
thiazoles
metformin
metformin
hypoglycemic agents
hypoglycemic agents
drug combinations
hypoglycemic agents
metformin
thiazoles
rosiglitazone-metformin combination
rosiglitazone-metformin combination
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone-metformin combination
rosiglitazone maleate
drug evaluation
package leaflet
summary of product characteristics

---
https://www.revmed.ch/RMS/2010/RMS-260/Activite-anticancereuse-de-la-metformine-nouvelles-perspectives-pour-une-vieille-molecule
2010
false
true
false
Switzerland
neoplasms
journal article
metformin
antineoplastic agents

---
http://hdl.handle.net/2268/82021
2010
false
true
false
Belgium
journal article
antineoplastic agents
metformin

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2010%20-%202019/2010/Septembre%202010/039-045DrFournier0910.pdf
2010
false
true
false
Canada
diabetes mellitus, type 2
hypoglycemic agents
hypoglycemic agents
hypoglycemic agents
hypoglycemic agents
drug combinations
drug therapy, combination
diagnostic self evaluation
journal article
metformin

---
http://www.cochrane.org/fr/CD002967
2010
United Kingdom
France
French
risk
acidosis, lactic
metformin
diabetes mellitus, type 2
metformin
hypoglycemic agents
administration, oral
review of literature
lactic acid
french abstract

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/avandia_avandamet_-_ct-9105.pdf
http://www.has-sante.fr/portail/jcms/c_1002684/avandia-avandamet
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/avandia_avandamet_ct_9105.pdf
2010
France
English
French
drug therapy, combination
diabetes mellitus, type 2
treatment outcome
rosiglitazone-metformin combination
hypoglycemic agents
thiazolidinediones
thiazolidinediones
insurance, health, reimbursement
rosiglitazone-metformin combination
drug combinations
administration, oral
metformin
thiazoles
metformin and rosiglitazone
hypoglycemic agents
rosiglitazone
rosiglitazone maleate
rosiglitazone maleate
evaluation of the transparency committee
Rosiglitazone
Rosiglitazone

---
https://www.minerva-ebp.be/fr/article/392
2009
false
false
minerva-ebm.be
Belgium
French
diabetes, gestational
metformin
hypoglycemic agents
insulin
treatment outcome
pregnancy
drug therapy, combination
hypoglycemic agents
metformin
insulin
pregnancy outcome
randomized controlled trials as topic
hypoglycemia
infant, newborn
adult
critical appraisal or critical reading
comparative study

---
http://www.has-sante.fr/portail/jcms/c_810817/avandamet
2009
France
French
rosiglitazone-metformin combination
drug combinations
metformin
thiazoles
hypoglycemic agents
administration, oral
tablets
insurance, health, reimbursement
diabetes mellitus, type 2
metformin and rosiglitazone
rosiglitazone maleate
thiazolidinediones
evaluation of the transparency committee
Rosiglitazone

---
http://www.has-sante.fr/portail/jcms/c_798093/eucreas
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-05/eucreas_-_ct-5439.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/eucreas_ct_5439.pdf
2009
France
English
French
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_713099/avandamet
2008
France
French
rosiglitazone-metformin combination
rosiglitazone-metformin combination
thiazolidinediones
metformin
drug combinations
hypoglycemic agents
tablets
administration, oral
insurance, health, reimbursement
diabetes mellitus, type 2
overweight
adult
aged
treatment outcome
hypoglycemic agents
thiazolidinediones
metformin
metformin and rosiglitazone
rosiglitazone maleate
rosiglitazone maleate
comparative study
evaluation of the transparency committee
Rosiglitazone
Rosiglitazone

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/031-035InfoPoems1208.pdf
2008
false
false
Canada
French
Otitis media acute
Cancer Pain Management
Cancer Pain
Evidence-Based medicine
treatment outcome
diabetes, gestational
metformin
hypoglycemic agents
antihypertensive agents
age factors
vaccination
infant
pain
dietary sucrose
aged
hypertension
breast neoplasms
ultrasonography, mammary
mammography
mass screening
otitis media
acute disease
Cancer Pain
Cancer pain
critical appraisal or critical reading

---
https://www.revmed.ch/RMS/2008/RMS-160/Place-de-la-metformine-dans-le-traitement-du-diabete-de-type-2-en-2008
2008
journal article
metformin
diabetes mellitus, type 2

---
https://www.minerva-ebp.be/fr/article/660
2007
false
false
minerva-ebm.be
Belgium
French
Insulin Glargine
hypoglycemic agents
diabetes mellitus, type 2
drug therapy, combination
thiazolidinediones
metformin
treatment outcome
Glycated Hemoglobin
blood glucose
administration, oral
injections
critical appraisal or critical reading
comparative study
Rosiglitazone

---
http://www.has-sante.fr/portail/display.jsp?id=c_401016
2006
France
French
hypoglycemic agents
metformin
drug combinations
thiazolidinediones
tablets
administration, oral
insurance, health, reimbursement
drug therapy, combination
diabetes mellitus, type 2
overweight
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone maleate
evaluation of the transparency committee
Rosiglitazone

---
http://www.has-sante.fr/portail/jcms/c_841933/eucreas-vildagliptine-/-metformine-antidiabetique-oral
http://www.has-sante.fr/portail/jcms/c_799890/eucreas-ct-5439
2006
France
French
nitriles
pyrrolidines
adamantane
hypoglycemic agents
metformin
diabetes mellitus, type 2
drug combinations
adult
administration, oral
dipeptidyl-peptidase iv inhibitors
treatment outcome
therapeutic equivalency
metformin and vildagliptin
guidelines for drug use
evaluation of the transparency committee
Vildagliptin

---
https://www.minerva-ebp.be/fr/article/710
2006
false
false
minerva-ebm.be
Belgium
French
hypoglycemic agents
Metabolic Syndrome
metformin
treatment outcome
life style
diet, reducing
exercise
risk factors
adult
critical appraisal or critical reading

---
http://www.has-sante.fr/portail/display.jsp?id=c_400975
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032556.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct_2784_glucophage_ang.pdf
2006
France
French
metformin
hypoglycemic agents
administration, oral
insurance, health, reimbursement
child
adolescent
diabetes mellitus, type 2
treatment outcome
metformin
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400139
2004
France
French
metformin
hypoglycemic agents
thiazolidinediones
drug combinations
administration, oral
diabetes mellitus, type 2
tablets
insurance, health, reimbursement
overweight
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone maleate
thiazolidinediones
evaluation of the transparency committee
Rosiglitazone

---
http://www.has-sante.fr/portail/display.jsp?id=c_399976
2004
France
French
tablets
metformin
hypoglycemic agents
thiazolidinediones
drug combinations
administration, oral
diabetes mellitus, type 2
overweight
insurance, health, reimbursement
treatment outcome
therapeutic equivalency
thiazolidinediones
hypoglycemic agents
metformin
rosiglitazone-metformin combination
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone maleate
rosiglitazone maleate
evaluation of the transparency committee
Rosiglitazone
Rosiglitazone

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.